Belmont, CA, United States of America

David R Cox

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 336(Granted Patents)


Location History:

  • St. Germain, WI (US) (2007)
  • Greensboro, NC (US) (2014 - 2018)
  • Belmont, CA (US) (2002 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David R. Cox

Introduction

David R. Cox is a prominent inventor based in Belmont, California, known for his significant contributions to genomic analysis and cancer research. With a remarkable portfolio of 20 patents, he has made strides in understanding the genetic basis of diseases and drug responses.

Latest Patents

Among his latest patents, one focuses on "Computer systems and methods for genomic analysis." This invention relates to methods for identifying variations in the human genome and linking these variations to the genetic basis of disease and drug response. It emphasizes the identification of individual SNPs, the determination of SNP haplotype blocks and patterns, and the application of these findings in whole genome analysis. Another notable patent is centered on "Markers for breast cancer," which provides correlations between polymorphisms and breast cancer. This patent outlines methods for diagnosing, prognosing, and treating breast cancer, along with systems and kits designed for these purposes.

Career Highlights

David R. Cox has worked with several notable companies throughout his career, including Perlegen Sciences, Inc. and Cambridge Enterprise Limited. His work has significantly impacted the fields of genomics and oncology, showcasing his dedication to advancing medical science.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Bradley A. Margus and Dennis G. Ballinger, contributing to various innovative projects and research initiatives.

Conclusion

David R. Cox's work exemplifies the intersection of technology and medicine, particularly in genomic analysis and cancer research. His patents and collaborations reflect a commitment to improving healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…